nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Baricitinib as a treatment for myasthenia gravis: a case report
|
Iguchi, Masahiro |
|
|
41 |
C |
p. 56-58 |
artikel |
2 |
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA
|
Coratti, Giorgia |
|
|
41 |
C |
p. 42-50 |
artikel |
3 |
Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy
|
Schiava, Marianela |
|
|
41 |
C |
p. 8-19 |
artikel |
4 |
Editorial Board
|
|
|
|
41 |
C |
p. IFC |
artikel |
5 |
ENMC Themed Workshop announcement
|
|
|
|
41 |
C |
p. I |
artikel |
6 |
Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3.
|
van der Woude, Danny R. |
|
|
41 |
C |
p. 1-7 |
artikel |
7 |
In Memoriam: Professor Stephan Zierz (1954-2024)
|
Joshi, Pushpa Raj |
|
|
41 |
C |
p. 40-41 |
artikel |
8 |
Quality of life in hypokalemic periodic paralysis - a survey
|
Holm-Yildiz, Sonja |
|
|
41 |
C |
p. 24-28 |
artikel |
9 |
Rapidly progressive myopathy: unveiling light chain amyloidosis as an initial manifestation of multiple myeloma: a case report and literature review
|
Kaminskiene, P. |
|
|
41 |
C |
p. 51-55 |
artikel |
10 |
Reliability and validity of cough peak flow measurements in myasthenia gravis
|
Kuroiwa, Ryota |
|
|
41 |
C |
p. 29-34 |
artikel |
11 |
Statins in hereditary myopathies: to give or not to give
|
Argov, Zohar |
|
|
41 |
C |
p. 35-39 |
artikel |
12 |
Treatment resistance in inclusion body myositis: the role of mast cells
|
Acosta, I. |
|
|
41 |
C |
p. 20-23 |
artikel |
13 |
WMS 2024 Congress Flyer
|
|
|
|
41 |
C |
p. II |
artikel |
14 |
WMS 2024 Congress information
|
|
|
|
41 |
C |
p. III |
artikel |
15 |
WMS General Information
|
|
|
|
41 |
C |
p. IV |
artikel |